Skip to main content
Tech.euFundingExplorerBeta

QV Bioelectronics

QV's GRACE implant will provide a paradigm shift in the treatment of glioblastoma (GBM), the most common form of primary brain cancer in adults that has amongst the worst outcomes of any type of cancer.

QV Bioelectronics has raised €11M across 6 funding rounds from 19 investors, most recently a round in Jan 2026. Based in Manchester, UK; active in Healthtech. Data as of 28 Oct 2026.

Total raised
€11M
€11,493,345
Funding rounds
6
Investors
19
distinct backers
Active since
2021-07
latest 2026-01

Funding by year

EUR raised per year · 2026 YTD
QV Bioelectronics — funding by year — interactive chart.
Data table
QV Bioelectronics — funding by year
2021€860k
2022€744k
2023€3.2M
2025€1.5M
2026€5.2M

Signals

High confidence
Raise-next likelihood38
base rate 30% for Other
  • ▲ In typical raise window
  • ▲ Up-round momentum
  • ▼ Low backer re-investment
Exit likelihood24
base rate 11% (2+ rounds)
  • ▲ 6 rounds raised
  • ▲ 5y since founding (typical exit age)
  • ▲ Recently backed by strong-exit-track investors

Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.